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	 	 IDF Cytocam SDF Microscan p value 
Animal 1 BASELINE 13.1±0.2 12.2±0.9 0.40 
	 SHOCK 11.1±2.6 7.2±2.5 0.33 
Animal 2 BASELINE 13.3±1.0 13.1±1.0 0.88 
	 SHOCK 9.2±1.0 9.8±1.6 0.79 
Animal 3 BASELINE 15.6±1.4 15.1±1.3 0.80 
	 SHOCK 13.1±1.0 13.3±1.6 0.96 
Animal 4 BASELINE 15.7±1.0 14.2±0.3 0.31 
	 SHOCK 14.2±1.8 14.9±0.2 0.73 
Animal 5 BASELINE Not analysed - insufficient quality video sequences 
	 SHOCK 8.7±0.7 10.5±1.2 0.22 
Animal 6 BASELINE 12.9±1.0 11.2±0.8 0.19 
	 SHOCK 12.8±1.0 14.0±1.9 0.60 
	
	
	 	 IDF Cytocam SDF Microscan p value 
Animal 1 BASELINE 2.9 (2.9-3.0) 3.0 (3.0) 0.40 
	 SHOCK 0.6 (0-1.7) 0.5 (0-2.0) 0.74 
Animal 2 BASELINE 2.9 (2.4-3.0) 2.9 (2.1-3.0) 0.41 
	 SHOCK 0.2 (0.1-0.6) 0.8 (0 -1.7) 0.86 
Animal 3 BASELINE 2.9 (2.7-3.0) 3.0 (3.0) 0.99 
	 SHOCK 2.7 (2-2.9) 3.0 (3.0) 0.63 
Animal 4 BASELINE 3.0 (2.9-3.0) 2.9 (2.8-3.0) 0.99 
	 SHOCK 2.7 (2.6-2.7) 2.3 (2.2-2.4) 0.10 
Animal 5 BASELINE Not analysed - insufficient quality video sequences 
	 SHOCK 1.1 (0.9-2.0) 0.6 (0 - 2.2) 0.69 
Animal 6 BASELINE 2.6 (2.4-2.9) 2.9 (2.9-3.0) 0.99 


























































































	 IDF Cytocam SDF Microscan p value 
Contrast (capillaries) 17.1±3.9 9.4±3.6 0.0006 
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Lactate	(mmol/l)	 4.6±2.2	 8.9±3.6	 0.001	
Standard	base	deficit	(mEq/l)	 2.1±4.1	 -4.6±5.5	 0.001	
PvCO2-PaCO2	(kPa)	 1.4±0.6	 1.9±0.7	 0.03	
SvO2	(%)	 56.1±9.5	 51.3±10.2	 0.27	
Lactate	clearance	(%)*	 73.4±10.3	 40.5±29.9	 <0.001	




































































































Group A: Above average PVD




















































































































Group A: Above average PVD












































































































































































































































































































































































































































































































































































































































































	 0.9	%	Saline	 Blood	Products	 MP4OX	
Above	average	PVD*			 3	 6	 5	













































































































































































































































ABOVE AVERAGE PVD BELOW AVERAGE PVD Timepoints are given as either shock phase 
or resuscitation (R) phase + number of 
minutes into phase






















































































































































































































































ABOVE AVERAGE PVD BELOW AVERAGE PVD(n=3) (n=7)
* p < 0.05 between groups at time point (2 way repeated measures ANOVA)
Timepoints are given as either shock 
phase or resuscitation (R) phase + 



























































































































































































































































ABOVE AVERAGE PVD Timepoints are given as either shock phase 
or resuscitation (R) phase + number of 
minutes into phase
* p<0.05 between groups at timepoint (2 way repeated measures ANOVA)
























































































































































































































































































































































































































































D7 SOFA > 6


































































D7 SOFA > 6






	 SOFA	>	6	(n=23)	 SOFA	<	6	(n=35)	 p	value	
Age	 49	(28-74)	 36	(27-46)	 0.06	













TVD	(mm/mm2)	 10.6±1.6	 11.8±1.6	 <0.01	
PVD	(mm/mm2)	 8.6±1.8	 11.2±1.8	 <0.01	
MFI	(AU)	 2.6	(2.2-2.8)	 2.8	(2.6-2.9)	 <0.01	
PPV	(%)	 88	(76-96)	 96	(92-99)	 <0.01	




MAP	(mmHg)	 76±18	 81±15	 0.26	
Lactate	(mmol/l)	 4.1	(2.1-6.9)	 2.2	(1.4-3.8)	 <0.01	
Base	Deficit	(mmol/l)	 -5.6	(-8.9	to	-2.1)	 -2.6	(-5.6	to	-0.2)	 0.05	
ScvO2	(%)	 71.6±5.7	 68.1±7.8	 0.20	








































































































D0 PVD > 10.33 


























Age	 44±20	 42±19	 0.74	






















Lactate	(mmol/l)	 3.1	(2.3-5.3)	 1.9	(1.5-3.7)	 0.02	
Base	Deficit	(MEq/l)	 -4.1	(-6.3	to	-2.1)	 -2.6	(-6.7	to-0.1)	 0.2	
ScvO2	(%)	 71±9	 69±4	 0.5	





























































































































































































































































































































































































































































































































































l) * SOFA > 6 (n=6)




































































SOFA < 6 (n=6)




























































SOFA  < 6 (n=6)

































SOFA > 6 (n=7)
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Abstract.
We report a new microcirculatory assessment device, the Braedius Cytocam, an Incident Dark Field (IDF) video microscope,
and compare it with a precursor device utilising side stream dark field (SDF) imaging.
METHODS: Time matched measurements were made with both devices from the sublingual microcirculation of pigs
subjected to traumatic injury and hemorrhagic shock at baseline and during a shock phase. Images were analysed for vessel
density, microcirculatory flow and image quality.
RESULTS: There were no differences in density or flow data recorded from the two devices at baseline [TVD IDF
14.2± 2.4/TVD SDF 13.2± 2.0, p 0.17] [MFI IDF 3 (2.8–3.0)/MFI SDF 3 (2.9–3.0), p 0.36] or during the shock state
[TVD IDF 11.64± 3.3/TVD SDF 11.4± 4.0 p = 0.98] [MFI IDF 1.9 (0.6–2.7)/MFI SDF 1.7 (0.3–2.6) p 0.55]. Bland and
Altman analysis showed no evidence of significant bias. Vessel contrast was significantly better with the IDF device for both
capillaries [17.1± 3.9 (IDF) v 3.4± 3.6 (SDF), p = 0.0006] and venules [36.1± 11.4 (IDF) v 26.4± 7.1 (SDF) p 0.014]
CONCLUSION: The Braedius Cytocam showed comparable vessel detection to a precursor device during both baseline
and low flow (shock) states.
Keywords: Microcirculation, sidestream dark field imaging, incident dark field imaging, haemorrhagic shock
1. Introduction
The microcirculation plays a critical role in the delivery of oxygen and substrates at a cellular level.
Microcirculatory impairment can lead to significantly increased morbidity and mortality across a
range of shock states [9, 13, 14] and significant impairment to microcirculatory flow may be present in
around a fifth of unselected patients within critical care units [15]. Assessment of the microcirculation
can occur through two broad and separate approaches; the first approach involves assessment of tissue
substrate delivery and uptake and the second relies on direct visualisation of microcirculatory vessels
in order to determine flow and density characteristics. Examples of the former approach include
Near Infra Red Spectroscopy (NIRS) [10] and fluorescence quench photometry [6] which provide an
estimation of tissue oxygenation and sublingual capnometry which, by assessing the degree of carbon
dioxide production in an individual tissue bed, provides a surrogate marker of perfusion [2, 16]. These
methods produce an aggregated overview of microcirculatory performance but may be influenced by
the heterogeneity that is often found in microcirculatory vessel beds. The second broad method of
microcirculatory assessment relies on the direct visualisation of small vessels (arterioles, venules and
capillaries) at various sites throughout the body. Historically this required the use of large microscopes
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and tissue dyes, so called intra vital microscopy, and was therefore mainly limited to experimental
work in small animal models. The development of handheld microscopes has revolutionised this area
of research. The first generation handheld devices used Orthogonal Polarised Spectroscopy (OPS)
imaging [5] which produced a somewhat limited field of view, whilst the devices were relatively bulky.
The next generation devices, used a Sidestream Dark Field (SDF) technique [4]. Similar to OPS in
theory, SDF technology involves illuminating the edges of the examined field with visible green light
in an 530 nm wavelength from a circular array of diodes. The light illuminates the target tissue from
the edges, whilst the field itself is excluded from external light. Haemoglobin (both oxygenated and
deoxygenated) absorbs the green light and thus appears black. Thus perfused blood vessels appear as
black lines on a white/greyscale background. Lighter gaps within blood vessels are caused by plasma
or by leucocytes. Producing qualitative data from SDF images requires editing and processing into
discrete sequences followed by off line analysis. Such analysis produces data on vessel density and
flow. At its most basic this analysis can be entirely manual consisting of a subjective assessment
of flow using a qualitative scale. More commonly semi automated software is used to assist in the
process, but a significant amount of user interaction is still required and each ten to twenty second
video sequence can take up to thirty minutes to process, even with an experienced analyst. Given the
widespread heterogeneity seen within the microcirculation during shock states it is important to obtain
a large number of video sequences, ideally five, at each time point being examined, thus increasing
the amount of video sequences that need to be analysed. This prolonged off line analysis has, thus
far, limited the use of this technique to research rather than as a clinical point of care perfusion test.
The latest generation of optical device for assessing the microcirculation is the Braedius Cytocam
(Fig. 1), which utilises an Incident Dark Field (IDF) technique. This technique, originally described
by Sherman and colleagues in the 1970s [12] is similar to Sidestream dark field illumination, in that
it uses a ring of circumferential LEDs to illuminate the target tissue tangentially, the illuminating
light being excluded from the central column of the microscope. However, the LED strobe speed
is significantly slower in the Cytocam device (2 ms versus 16 ms); this theoretically produces less
distortion of the erythrocyte image potentially allowing more accurate automated flow analysis. The
Cytocam is a small handheld camera, which weighs considerably less than the previous generation
Microscan SDF device (Fig. 2) (115 versus 350 grams). It is also less bulky than the SDF device and
this has the effect of making it easier for the operator to manipulate (Fig. 3). In turn this has the potential
to reduce pressure artifacts caused by the tip of the device occluding flow in microcirculatory vessels.
The Cytocam has a higher optical resolution than the Microscan (3.12 versus 4.54 micrometers) and
a wider field of view (1.79 mm2 versus 0.84 mm2). This larger field of view enables the user to more
quickly identify suitable areas of microcirculation for analysis. The Cytocam has an electronically
driven focusing motor as opposed to the analogue focusing mechanism of the Microscan making it
easier to carry out fine focusing actions. Additionally the device returns to the same focus depth for
subsequent measurements, speeding up the time taken to acquire images. The Cytocam is linked to a
dedicated computer with integral software which controls image acquisition, editing and potentially on
line analysis. This is in contrast to the previous generation devices which required analogue to digital
signal conversion through a signal adapter as well as bulky separate batteries and a non proprietary
laptop computer with adapted software.
In this paper we report a series of experiments designed to assess the performance of the Cytocam
IDF device and to compare and contrast it to it’s immediate predecessor, the Microscan SDF device.
In the first part of the study, the Cytocam is directly compared with the Microscan in an existing large
animal model of haemorrhagic shock and complex injury. The aim is to compare the performance
of the devices with a particular focus on vessel identification. The second part of study is a direct
comparison of image quality between the two devices, using matched sublingual microcirculatory
images, obtained from one of the study investigators.
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Fig. 1. Microscan SDF video microscope. Green polarized light, produced from a ring of circumferential LEDs is transmitted
to the tissue and absorbed by haemoglobin. Residual light returns to the video camera via a magnifying lens and focus
mechanism. Analogue images are converted to digital and viewed on a stand alone laptop computer.
2. Methods
Conduct of this research was approved under license from the United Kingdom Home Office:
Animals (Scientific Procedures Act) 1986.
2.1. Subjects
Briefly, six terminally anaesthetised and surgically prepared large white pigs, were subjected to a
controlled haemorrhage and reproducible extremity injury and, in some instances, blast wave exposure.
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Fig. 2. Cytocam IDF video microscope. Green light is produced from circumferential LEDs in a similar way to the SDF
device. However image quality is improved by a higher resolution camera. The device is also simpler with fewer connections
and accessories required.
Following a 30 minute shock phase the animals were resuscitated using differing resuscitation strate-
gies that are outside the scope of this paper, but which have been reported elsewhere [7, 8]. The
experiment ended at four hours after the commencement of resuscitation at which point the animals
were euthanised.
The aspect of the study examining image contrast required two closely matched microcirculatory
images, obtained from the subject devices. In practice, this was not possible within the constraints of
our existing experimental setup. We therefore obtained these images from the sublingual region of one
of the investigators (SDH).
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A
B
Fig. 3. Cytocam IDF (A) and Microscan SDF (B) devices.
2.2. Vessel identification and flow assessment
Two devices were used to record video images of the sub lingual microcirculation, utilising Incident
Dark Field (IDF) technology (Cytocam, Braedius Medical, Amsterdam, NL) or Sidestream Dark Field
(SDF) technology (Microscan, Microvision Medical, Amsterdam, NL).
Serial video images of the sublingual microcirculation were recorded at the following experimental
time points: Baseline (a steady state time point prior to injury or blood loss) and Shock (15 minutes after
extremity trauma, controlled blood loss and blast wave injury). The shock time point represents a low
flow state, with a degree of dynamic response within the microcirculation in contrast to the predictable
steady state seen at baseline. At each time point at least three and ideally five ten second sequences
were recorded using each device, in accordance with accepted consensus opinion on assessment of the
microcirculation [3]. Images were recorded using the SDF device (Microscan), immediately followed
by the IDF device (Cytocam). Images were either directly recorded onto a dedicated integral panel PC
using integral software (Cytocam Tools v. 7.1, Braedius Medical) or via an analogue to digital signal
converter (Canopus, ADVC 110) onto a stand alone laptop computer (Microscan). Microscan acquired
images were saved as digital DV-AVI files, whilst those acquired by the Cytocam were converted to
this format during export using integral software. As previously mentioned the field of view from
the Cytocam is considerably wider than that obtained using the Microscan necessitating a reduction
in the field of view during export to DV-AVI format. Video captures were all performed by a single
operator. All images were recorded from the same part of the sublingual area, to the left side of the
midline. Care was taken to minimise pressure artefact, by applying the probe tip and pulling back until
contact was just lost and then reapplying with the minimum amount of pressure required to produce
an image. Focus was adjusted by the operator in order to produce the best possible vessel definition,
either manually (Microscan) or via the integral software linked to the electronic focusing mechanism
(Cytocam). Videos were assigned a five digit random number prior to archiving in order to reduce bias
during interpretation. The videos were linked to study time point and device by reference to a separate
database. Videos were exported in DV-AVI format and with standardised characteristics. Video files
were saved on an external hard drive prior to off line analysis.
Analysis of video sequences was carried out by a single operator using dedicated software (AVA 3.0,
Automated Vascular Analysis, Microvision Medical, NL). The operator was blinded to both the device
used for recording and the time point of the video sequence. Only video sequences that conformed
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IDF SDF
Fig. 4. Matched images from sublingual microcirculation used for quality comparison. Points used for image analysis circled
(blue = venules, red = capillaries).
to pre determined standards of stability, focus, illumination, length and absence of pressure artefacts
were included in the analysis. These standards were detailed by Massey et al. in a previous study [11].
All visible vessels were manually traced by the operator and flow characteristics were assigned to each
individual vessel segment, using a four point scale originally described by Boerma et al. [1]. The mean
flow across all segments was calculated in order to produce an overall Microcirculatory Flow Index
(MFI) for each video sequence. Analysis of each video sequence produced data for the total number
of vessel segments compared to the size of the analysis area (Total Vessel Density, TVD).
2.3. Vessel contrast assessment
Vessel contrast and sharpness was analysed using a technique originally described by Goedhart
etl al. [4] To compare vessel contrast between the two devices a single operator obtained two near
identical images from their own sublingual microcirculation, using the two subject devices. Optimal
image characteristics were obtained with respect to focus, illumination and avoidance of pressure.
Video sequences were examined and one video frame, demonstrating the highest quality of focus and
illumination, was selected for each device. This video frame was saved as a Portable Network Graphic
(PNG) file. In each video frame image, ten venule segments and ten capillary segments were selected
for quality analysis. (Fig. 4) To determine vessel contrast and sharpness, cross sectional grey scale
profiles (greyscale value 0 corresponding to black and 255 to white) were obtained using Image J
software (freeware developed by the US National Institute for Health). The contrast was defined as the
absolute difference between the minimum value within the vessel and the maximum value on either
side of the vessel wall (average of the two sides of the vessel).
2.4. Statistical analysis
Statistical Analysis was performed using GraphPad Prism version 6. Data was tested for normality
using D’Agostino & Pearson omnibus normality test. Students paired t tests were used to compare
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Table 1
Total Vessel Density (TVD) values recorded from each device at baseline and shock time points.
Units are mm/mm2 and values are expressed as mean± standard deviation
IDF Cytocam SDF Microscan p value
Animal 1 BASELINE 13.1± 0.2 12.2± 0.9 0.40
SHOCK 11.1± 2.6 7.2± 2.5 0.33
Animal 2 BASELINE 13.3± 1.0 13.1± 1.0 0.88
SHOCK 9.2± 1.0 9.8± 1.6 0.79
Animal 3 BASELINE 15.6± 1.4 15.1± 1.3 0.80
SHOCK 13.1± 1.0 13.3± 1.6 0.96
Animal 4 BASELINE 15.7± 1.0 14.2± 0.3 0.31
SHOCK 14.2± 1.8 14.9± 0.2 0.73
Animal 5 BASELINE Not analysed – insufficient quality video sequences
SHOCK 8.7± 0.7 10.5± 1.2 0.22
Animal 6 BASELINE 12.9± 1.0 11.2± 0.8 0.19
SHOCK 12.8± 1.0 14.0± 1.9 0.60
vessel density data which was normally distributed. Mann Whitney U tests were used to compare
vessel flow data, which did not have a normal distribution. Bland – Altman distribution analysis was
performed on the TVD results from the two devices. Contrast values for the two devices were analysed
using paired t tests after confirming normal distribution. A p value of < 0.05 was considered to be
statistically significant.
3. Results
3.1. Vessel identification and flow assessment
Results from six animals were included in the study. Forty four video sequences were obtained with
each device, giving a total of eighty eight matched video sequences. In order to assess for possible
variance at different flow states video sequences were subdivided into Baseline (n = 40) and Shock
(n = 48) time points. As expected there was a wider spread of results during the shock time point as the
microcirculation demonstrated increased heterogeneity. By contrast the Baseline time point was more
homogenous representing a relatively steady state at this stage of the experiment. One experimental
time point was excluded as at least three video sequences of sufficient quality could not be obtained.
There were no significant differences in vessel detection, expressed as the Total Vessel Density,
recorded by the two devices at either the baseline or shock time points (Table 1).
There was also no difference in the observed Microvascular Flow Index, recorded by the two devices
at either experimental time point. These findings are consistent when the data is aggregated (Fig. 5) or
examined for each individual animal (Table 2).
Bland Altman analysis confirms the comparability of data collection from each device and shows
no evidence of bias (Fig. 6).
3.2. Vessel contrast and sharpness
Vessel contrast was significantly higher in the image obtained from the Cytocam IDF device. This
applied to both capillary and venules (Table 3, Fig. 4).
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Fig. 5. Aggregated IDF and SDF data for flow and density parameters.
Table 2
Microvascular Flow Index (MFI) values recorded from each device at baseline and shock time points.
Units are arbitrary units of flow ranging from 0 (no flow) to 3 (continuous flow). The average
value of flow in all vessel segments is presented. Values are expressed as median with
95% confidence interval
IDF Cytocam SDF Microscan p value
Animal 1 BASELINE 2.9 (2.9–3.0) 3.0 (3.0) 0.40
SHOCK 0.6 (0–1.7) 0.5 (0–2.0) 0.74
Animal 2 BASELINE 2.9 (2.4–3.0) 2.9 (2.1–3.0) 0.41
SHOCK 0.2 (0.1–0.6) 0.8 (0–1.7) 0.86
Animal 3 BASELINE 2.9 (2.7–3.0) 3.0 (3.0) 0.99
SHOCK 2.7 (2–2.9) 3.0 (3.0) 0.63
Animal 4 BASELINE 3.0 (2.9–3.0) 2.9 (2.8–3.0) 0.99
SHOCK 2.7 (2.6–2.7) 2.3 (2.2–2.4) 0.10
Animal 5 BASELINE Not analysed – insufficient quality video sequences
SHOCK 1.1 (0.9–2.0) 0.6 (0–2.2) 0.69
Animal 6 BASELINE 2.6 (2.4–2.9) 2.9 (2.9–3.0) 0.99
SHOCK 2.7 (2.4–2.8) 3 (2-3) 0.70
4. Discussion
We have described a series of experiments designed to assess the performance of a new device for
assessing the microcirculation, the Braedius Cytocam. To our knowledge this is the first such evaluation
of the Cytocam IDF device performed over a range of flow states, in an experimental model of shock.
Our experimental setup was designed to replicate as closely as possible conditions found within a
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Fig. 6. Bland Altman plot showing density data produced from IDF and SDF devices across all experimental time points.
Table 3
Contrast values from two matched microcirculation images recorded
from the two devices. 10 individual points were assessed for both capillaries
and venules (see Fig. 4). Units are arbitrary units of pixel intensity. Higher
values indicate a greater contrast between vessels and vessel borders
IDF Cytocam SDF Microscan p value
Contrast (capillaries) 17.1± 3.9 9.4± 3.6 0.0006
Contrast (venules) 36.1± 11.4 26.4± 7.1 0.014
clinical environment. We feel that this adds considerable value to this study as it enables a comparison
of the two imaging devices under conditions that closely replicate that which will be encountered in
clinical practice. The inclusion of imaging comparisons at low flow shock states is often omitted from
validation studies, which are usually conducted on healthy volunteers under controlled conditions. By
including these low flow images in this study we have produced a comparison between the two devices
over the full operating range in which they would be used in clinical practice.
In the first part of the study we showed that, in the pragmatic setting of an existing trial, the two
devices performed in a comparable fashion and the data obtained, with respect to both vessel density and
flow, was virtually indistinguishable. By selecting a baseline steady state timing point we attempted
to reduce any changes in the microcirculation seen between the recording of the SDF and the IDF
acquired images. The addition of the shock timing point is important because it allows a comparison
of the two devices at a low flow state, where vessel identification may be predicted to be more difficult.
However, at this time point the microcirculation was in a state of flux, induced by haemorrhage and
injury, and this can be seen in the much wider spread of data. Despite this dynamism and heterogeneity
there is still a remarkable similarity between the results collected from the two devices. As far as
possible we attempted to reduce the time between image acquisition, which in practice was achieved
within five minutes from the start of SDF collection to the end of IDF collection.
270 S. Hutchings et al. / The Cytocam video microscope
We acknowledge that this approach has limitations and that it would be optimal to compare identical
images derived from the two devices. However, in practical terms it is extremely difficult to find
even two such images, given the magnification and field of view constraints as well as the instability
inherent in the use of handheld cameras. In reality it is impossible to obtain matched images in a
dynamic study that includes animals or patients with shocked microcirculations. The first part of our
study therefore represents an attempt to answer the question of comparability of data generated by
the two devices, rather than a completely objective assessment of image identification under perfect
operating conditions.
In the second part of this study we examined whether the image quality produced by the IDF device
was superior to that of the SDF device. Subjectively, we felt that the IDF images were sharper and
had greater definition than the precursor SDF images and were able to confirm this objectively on
one matched image using pixel analysis software. Further studies are needed to replicate this finding
which is of potential importance as sharper images and improved contrast between blood vessels
and background tissue potentially make the automated analysis of such images by computer software
more achievable. Automated analysis programs cannot yet reliably measure vessel density in recorded
video-microscopy images and improvements in image quality are a necessary prerequisite for the
development of this technology.
In summary the Braedius Cytocam is a new device for imaging the microcirculation which we have
validated against a common precursor device. Microcirculatory data produced by the two devices
is comparable and this should allow researchers to confidently transition to the new device whilst
maintaining the integrity of data previously recorded with precursor technology.
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Abstract
Background: Traumatic hemorrhagic shock (THS) is a leading cause of preventable
death following severe traumatic injury. Resuscitation of THS is typically targeted at
blood pressure, but the effects of such a strategy on systemic and microcirculatory
flow remains unclear. Failure to restore microcirculatory perfusion has been shown
to lead to poor outcomes in experimental and clinical studies. Systemic and
microcirculatory variables were examined in a porcine model of complex THS,
in order to investigate inter-individual variations in flow and the effect of
microcirculatory perfusion on reversal of the shock state.
Methods: Baseline standard microcirculatory variables were obtained for 22 large
white pigs using sublingual incident dark field (IDF) video-microscopy. All animals were
subjected to a standardised hind-limb injury followed by a controlled haemorrhage of
approximately 35 % of blood volume (shock phase). This was followed by 60 min of
fluid resuscitation with either 0.9 % saline or component blood products and a target
SBP of 80 mmHg (early resuscitation phase). All animals were then given blood
products to a target SBP of 110 mmHg for 120 min (mid-resuscitation phase), and a
further 100 min (late resuscitation phase). IDF readings were obtained at the midpoint
of each of these phases. Cardiac output was measured using a pulmonary artery
catheter. Animals were divided into above average (A) and below average
(B) perfused vessel density (PVD) groups based on the lowest recorded PVD
measurement taken during the shock and early resuscitation phases.
(Continued on next page)
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Results: There was minimal inter-individual variation in blood pressure but wide
variation of both systemic and microcirculatory flow variables during resuscitation.
During shock and early resuscitation, group A (n = 10) had a mean PVD of 10.5
(SD ± 2.5) mm/mm2 and group B (n = 12) 5.5 (SD ± 4.1) mm/mm2. During the later
resuscitation phases, group A maintained a significantly higher PVD than group B.
Group A initially had a higher cardiac output, but the difference between the groups
narrowed as resuscitation progressed. At the end of resuscitation, group A had
significantly lower plasma lactate, higher lactate clearance, lower standard base deficit
and smaller mixed venous-arterial CO2 gradient. There was no significant difference in
blood pressure between the two groups at any stage.
Conclusion: There was a wide variation in both macro- and microcirculatory flow
variables in this pressure-targeted experimental model of THS resuscitation. Early
changes in microvascular perfusion appear to be key determinants in the reversal of the
shock state during resuscitation. Microcirculatory flow parameters may be more reliable
markers of physiological insult than pressure-based parameters and are potential targets
for goal-directed resuscitation.
Keywords: Haemorrhagic shock, Microcirculation, Traumatic injury, Sublingual
video-microscopy, Lactate clearance, CO2 gap, Blood products, Perfused vessel density
Background
Traumatic hemorrhagic shock (THS) is a leading preventable cause of death following
severe traumatic injury [1–3], and timely reversal of the shock state is essential in
reducing post-injury morbidity and mortality.
Resuscitation from THS is invariably conducted with reference to a pressure-based
paradigm that currently emphasises so-called "permissive hypotension". This strategy is
based on the hypothesis that excessive blood and fluid administration, given with the
goal of achieving normotension, may lead to clot disruption and increased bleeding.
This is seemingly well supported by experimental [4] and clinical [5] evidence and
recommended by expert authorities [6, 7]. Crucially, however, the effects of pressure-
targeted resuscitation upon blood flow, especially microcirculatory blood flow, are less
well defined.
The microcirculation is a collective term for the network of small blood vessels that
perform the final role in the delivery of cellular oxygen and substrate and is therefore of
paramount importance during shock and resuscitation. Small animal studies have shown
that the ability to maintain microcirculatory perfusion is critical to outcome following
THS [8]. However, these studies utilised models of simple haemorrhage and may have
limited translation into clinical practice. To date, only one published clinical study has
examined the effects of microcirculatory impairment on end-organ function following
THS [9], finding that there was an association between microcirculatory impairment and
organ failure. However, this study examined the microcirculation in the period after
haemodynamic stability had been restored, not during the shock phase itself.
If it could be demonstrated that individuals with THS who were able to maintain
higher systemic and microcirculatory blood flows during resuscitation had improved
outcomes, then this could potentially identify avenues for the development of novel
end points of resuscitation based on flow-based parameters.
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The current study presents data on macro- and microcirculatory blood flow collected
from a porcine experimental model of THS. The aims of the study are to investigate (i)
inter-individual variations in systemic and microcirculatory blood flow, (ii) the
relationship between systemic and microcirculatory blood flow and (iii) to examine
whether animals which maintained a higher degree of microcirculatory perfusion during
shock and resuscitation had more effective and timely reversal of the shock state.
Methods
Study design
This is an opportunistic prospective observational study that investigates the haemo-
dynamic and microcirculatory variables for some of the subjects of a previously pub-
lished porcine experimental study. The original experimental study was undertaken to
address the effects of different initial resuscitation fluids on the development of
trauma-induced coagulopathy, the results of which have been published elsewhere [10].
Data were obtained from experiments conducted with the presence of an investigator
trained in the acquisition of microcirculatory images.
Animal preparation
The whole experiment was approved and conducted under license from the Home
Office Animals (Scientific Procedures) Act 1986.
The full animal preparation is described in detail elsewhere [10]. In summary, female
large white pigs (43–56 kg) were terminally anaesthetised and allowed spontaneous
respiration following tracheal intubation. The left femoral artery and left common
carotid arteries were cannulated to allow the withdrawal of blood and infusion of
resuscitative fluid, respectively. Cardiac output monitoring was performed using a
pulmonary artery catheter (Vigilance Volumetrics CEDV; Edwards Lifesciences Ltd).
The bladder was catheterised. A midline laparotomy and splenectomy was performed,
and the abdomen was closed.
Experimental protocol
The full experimental protocol is detailed previously [10, 11] and was designed to
replicate battlefield injury, shock and subsequent resuscitation. The experiment was
designed to keep all animals alive until the end of resuscitation. A proportion of
animals received a controlled blast injury, and all animals received a controlled hind-
limb injury from a captive bolt gun as described elsewhere [10]. Following the haemor-
rhagic shock phase, animals were assigned to receive initial resuscitation with either (a)
0.9 % saline or (b) component blood therapy consisting of leucodepleted porcine red
blood cells and plasma (delivered in a 1:1 ratio). The sampling, storage and preparation
of these blood products are described in detail elsewhere [10].
Data was collected at five time points as follows:
(a)Baseline (pre-injury)
(b)Shock (30 min after controlled haemorrhage and injury)
(c)Early (hypotensive) resuscitation (30 min after commencement of resuscitation)
(d)Mid-resuscitation (90 min after commencement of resuscitation)
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(e)Late resuscitation (170 min after commencement of resuscitation)
In accordance with currently accepted trauma shock resuscitation protocols, the
target systolic blood pressure was set at 80 mmHg for the early resuscitation phase and
110 mmHg during subsequent resuscitation phases. Animals were given boluses of fluid
to achieve these pressure targets. During early resuscitation, animals were treated with
either 0.9 % saline or blood products. During mid- and late resuscitation, all animals
exclusively received blood products.
Microcirculatory monitoring
The microcirculation was assessed using incident dark field (IDF) video-microscopy
(Cytocam, Braedius Medical B.V), which has been recently validated against a precursor
device in this setting [12]. Video clips of the microcirculation were acquired from the
sublingual area at each of the five time points. Images were acquired by three operators
but reviewed for quality by a single experienced operator. At least three (and ideally
five) video sequences, of at least five seconds duration, were recorded at each time
point, in accordance with the current consensus for assessing the microcirculation [13].
Quality assessment criteria were used to optimise image quality according to standard
practice [14]. Each video sequence was assigned a five-digit random number when
saved to digital media. Images were therefore de-identified with respect to animal,
treatment and time point.
Analysis of microcirculation video clips
Analysis was conducted offline by a single operator (S.H.) using semi-automated
software (Automated Vascular Analysis v. 3.0, Microvision Medical, NL). All vessels
were identified and traced by hand. Only small vessels (< 20 μm diameter) were
included in the analysis. Results were obtained for the following variables:
(i) Total vessel density (TVD); the total numbers of vessels in the visual field.
(ii)Microcirculatory flow index (MFI), originally described by Boerma et al. (27) rates
each quadrant of the image in terms of the most appropriate flow rating (0 = no flow;
1 = intermittent flow; 2 = sluggish flow; 3 = continuous flow). To improve the accuracy
of this measurement, we ascribed MFI values to each individual vessel segment and
the mean value for each video sequence was calculated.
(iii)Perfused vessel density (PVD); the total number of vessels in the visual field with
either sluggish or continuous flow.
Microcirculatory perfusion
Animals were divided ex priori into two groups classed as having above average (group
A) and below average (group B) microcirculatory perfusion based on their lowest PVD
values. PVD was selected as the discriminator as it is a composite marker composed of
both vessel density and flow data. Firstly, the lowest PVD during the shock and early
resuscitation phases was calculated for each of the 22 animals. Then the mean of all
these PVD values (for all animals) was selected as the reference point above and below
which groups A and B were, respectively, divided.
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End points of resuscitation
Since the experimental protocol was designed for all animals to survive, we chose
endpoints reflective of the degree of shock reversal. The primary measure of shock
reversal was lactate clearance (% change between early and late resuscitation time points).
Lactate concentration, standard base excess and the gradient between mixed venous and
arterial PCO2 (CO2 gap) at the late resuscitation time point were selected as secondary
endpoints. Urine output was used as a surrogate marker of renal perfusion.
Statistical analysis
Data analysis was performed using Prism version 6.0 (GraphPad). Data was
assessed for normality using D’Agostino-Pearson omnibus normality test. Repeated
t tests or Mann-Whitney U tests with Holm-Sidak correction for multiple compari-
sons were used to assess for differences between groups. A p value of < 0.05 was
considered significant.
Results
Data was collected on twenty-two animals which survived to the end of resuscitation.
During initial resuscitation, 12 animals received blood products and ten 0.9 % saline.
Ten animals were exposed to blast.
Inter-individual variation in macro- and micro-haemodynamic variables
Macro-circulatory flow and pressure variables and microcirculatory perfusion variables
showed a similar trend during shock and resuscitation (Fig. 1a–c). However, although
blood pressure, as the targeted parameter, showed little variation between animals
(Fig. 1a), there was a wider variation in both cardiac output (Fig. 1b) and PVD (Fig. 1c).
During the shock and early resuscitation phases, the mean of the lowest recorded PVD
for all animals was 6.2 mm/mm2 and this value was used to divide animals into groups
with above average (group A) and below average (group B) microcirculatory perfusion.
Illustrative IDF video sequences from these two groups are provided in the supplementary
electronic information (Additional file 1: Video 1 and Additional file 2: Video 2).
Expectedly, there was no difference in blood pressure between animals in groups A
and B (Fig. 2a). PVD in animals with above average perfusion during shock and early
resuscitation returned to baseline by the end of the experiment in contrast to those in
the below average perfusion group in whom it remained depressed (Fig. 2b). The
cardiac output fell sharply following haemorrhage in both groups, but the difference
between the groups was less pronounced and became non-significant as resuscitation
progressed (Fig. 2c). Animals in group A had significantly lower systemic vascular
resistance during the shock and early resuscitation phases than those in group B (group
A 1086 ± 296, group B 1503 ± 319 dyn s cm−5 p = 0.002). By the end of the experiment,
there was no difference in cardiac output between the two groups but a persisting gap
in microcirculatory perfusion.
Effect of microcirculatory perfusion on shock reversal
Data on shock reversal variables are presented in Table 1. Group A had a significantly
higher lactate clearance than group B. At the end of the experiment, group A also had
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a lower standard base deficit, lower final lactate concentration and a reduced CO2 gap
compared to group B. There was a trend to higher urine output in group A, but this
did not reach significance.
We further analysed each group of animals based on the type of initial resuscitation




Fig. 1 Changes in mean arterial pressure (MAP) (a), cardiac output (CO) (b) and perfused vessel density
(PVD) (c), during shock and resuscitation. Values shown as mean (SD) of all animals at each time point
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Fig. 2 Differences in mean arterial pressure (MAP) (a), perfused vessel density (PVD) (b) and cardiac output
(CO) (c), between animals with above average and below average perfusion recorded during shock and
early resuscitation
Table 1 Markers of shock reversal at the end of resuscitation in animals with above and below
average perfused vessel density (PVD) recorded during shock and early resuscitation
Group A Group B p value
(Above average PVD) (Below average PVD)
n = 10 n = 12
Tissue perfusion variables, mean (SD)
Lactate at late resuscitation (mmol/l) 4.9 (2.5) 8.6 (3.7) 0.02*
Lactate clearance during resuscitation (%) 73.1 (11.9) 40.7 (32.3) < 0.001*
Standard base deficit at late resuscitation 1.3 (4.3) -4.8 (5.7) 0.01*
(PvCO2–PaCO2) at late resuscitation (kPa) 1.3 (0.6) 2.1 (0.7) 0.03*
Urine output (ml)a 260 (163) 168 (152) 0.25
*Significant using two-tailed t test
aCumulative between shock phase and end of experiment
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these four groups was too small for statistical significance, the impact of impaired
microcirculatory perfusion can be observed within each group of identically treated
animals (Fig. 3).
Effect of initial resuscitation fluid and blast exposure
Animals treated with 0.9 % saline as the initial resuscitation fluid had significantly lower
PVD prior to treatment than those that received blood products. Although there was a
suggestion that animals initially treated with 0.9 % saline continued to have a lower
PVD throughout subsequent resuscitation (Fig. 4), further meaningful analysis was
precluded by this lack of homogeneity prior to treatment. Examining the effects of
administration of initial resuscitation fluid on PVD in each individual animal also failed
to reveal a uniform trend (Fig. 5). There were no discernable differences in lactate
clearance or final lactate concentration based purely on the type of initial resuscitation
fluid used (Additional file 3).
Ten out of twenty-two animals were exposed to blast injury. There were no apparent
differences in either macro- or microcirculatory variables between animals attributable
to blast exposure, nor in the lactate profile, although further analysis was confounded
by the heterogeneity of fluid treatments applied (Additional file 4).
Discussion
The main finding of this study is that in a large animal model of complex traumatic
injury and haemorrhagic shock, with resuscitation targeted at systolic blood pressure,
there is wide inter-individual variations in both macro- and microcirculatory flow
variables. Furthermore, animals which were able to maintain flow, both at the systemic
and microcirculatory level, had more timely reversal of the shock state during
resuscitation.
Our study adds to the previous work conducted by Dubin and co-workers [15] who
showed that microcirculatory flow fell in line with cardiac output during the early
phases of haemorrhage in an ovine model. Our study supports these findings but
further shows that there is a group of animals in whom the reduction in microcircula-
tory perfusion appears less marked and that these animals exhibit a more rapid reversal
Fig. 3 Differences in lactate concentration at the end of resuscitation between animals with above and
below average microcirculatory perfusion recorded during shock and early resuscitation. Animals are
grouped by initial resuscitation fluid
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of the shock state during subsequent resuscitation. Although microcirculatory flow did
initially follow cardiac output in our experimental model, the coherence between
macro- and microcirculatory flow was, to some extent, lost during late resuscitation.
A feasible physiological explanation of our study findings is that those animals with
below average microcirculatory perfusion during shock and early resuscitation have
responded to a fall in cardiac output with excessive vasoconstriction compared to
animals with above average perfusion. Such excessive vasoconstriction, above that
required to maintain organ perfusion pressure, may lead to microcirculatory impair-
ment and consequent tissue hypo-perfusion, leading to the reduced lactate clearance
observed in this group. Precisely why some animals responded to an equivalent insult
with differing degrees of vasoconstriction remains unexplained, and further investiga-
tive work is required to elucidate the exact mechanistic processes involved.
In the clinical setting, the identification of patients who have poor microcirculatory
flow during shock and early resuscitation may potentially lead to important changes in
management. Such an approach could see the introduction of more individualised
therapy, and this would have a better physiological rationale than a blanket ‘one size fits
all’ pressure-targeted resuscitation strategy. Xu and co-workers elegantly demonstrated
that targeting microcirculatory perfusion rather than blood pressure leads to less fluid
administration with no detriment to outcome in a porcine model of THS [16]. The use
of hand-held video microscopes combined with a point-of-care assessment tool for
bedside video analysis may allow the introduction of such a strategy into clinical
practice. There are early indications that this may be feasible [17]. Adoption of such
systems into clinical practice may allow the development of new resuscitation protocols
for THS based around flow rather than pressure targets.
Failure to normalise the microcirculation following resuscitation has significant
effects on organ function [18]. It is common for critically ill septic patients to have a
disjunction between macro- and microcirculatory function, and this has also been
Fig. 4 Changes in perfused vessel density (PVD) in animals initially resuscitated with 0.9 % saline (n = 10)
or blood products (n = 12). Values shown as mean (SEM) of all animals at each time point
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recently demonstrated in patients following THS [9]. Previous preclinical studies of
experimental haemorrhagic shock have variably demonstrated either recovery [19] or
persistence [20, 21] of microcirculatory dysfunction after systemic haemodynamic
variables have been restored. Whilst our results show that microcirculatory perfusion
broadly follows systemic blood flow in returning to normal levels following resuscita-
tion, there were a group of animals in whom the microcirculation continued to be
disproportionately impaired. Our results suggest that those animals which show very
significant falls in microcirculatory impairment during the shock period never return to
baseline values of perfusion, in contrast to those with more modest initial falls in
Fig. 5 Changes in perfused vessel density (PVD) in individual animals after administration of initial
resuscitation fluid. Values are recorded 15 min before (SHOCK) and 30 min after (EARLY RESUS)
commencement of fluid resuscitation
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perfused vessel density. Possible explanations for persisting microcirculatory failure
after restoration of systemic blood flow include dysfunction of any or all of the individ-
ual elements that make up the microcirculation, for example, endothelial cell swelling
caused by ischaemia and re-perfusion injury [22], clogging of small vessels with
activated leucocytes [23] and dysfunction of transfused stored erythrocytes leading to
vessel occlusion [24]. Our study was only designed to assess the initial response of the
microcirculation to shock and resuscitation, and further studies are required to answer
these interesting questions relating to the precise mechanisms behind persistent micro-
circulatory dysfunction.
Our study was opportunistic in nature and although we prospectively collected data,
we not unsurprisingly ended up with groups of animals which had received a variety of
heterogeneous injuries and treatments. We did examine the data to determine if there
was any discernible effect of differing fluid administration on microcirculatory
perfusion in animals which received saline and blood products but failed to find a
unifying pattern. In part, this was because animals which received saline had a signifi-
cantly lower PVD during the shock phase prior to initial treatment, precluding subse-
quent analysis. Other studies have appeared to show enhanced microcirculatory
perfusion following the administration of fluids with higher viscosities [25, 26], but
many of these were conducted in small animals with limited translatability into the
clinical setting. Furthermore, of the small number of large animal studies conducted in
this field [27, 28], none examined complex injury as opposed to simple blood loss,
again limiting the potential for translation. The interesting question of which fluid
more effectively resuscitates the microcirculation is still not fully answered, and further
studies specifically designed to address this question in a model of complex THS would
be of value.
Our study has several limitations, the most obvious being the heterogeneity of the
applied treatments. In order to reduce the use of animals, we collected data from an
existing experimental model, whose primary aim was to detect differences in trauma
coagulopathy based on the choice of initial resuscitation fluid. Furthermore, in order to
replicate recent military combat conditions, some animals were exposed to blast injury.
We were unable to control for these variations in our small sample size.
Despite the pre-allocation of animals into 0.9 % saline and blood product groups,
these groups were statistically different, in terms of PVD, even before the start of
resuscitation. This made further detailed comparison of animals based on the type of
fluid difficult.
The authors also recognise the limitation of not having survival as an outcome
measure in this observational study; ideally, this would be a useful translatable outcome
for clinical relevance. However, the experiment was designed for all animals to survive
until the end of the protocol. Therefore, surrogate markers of shock reversal such as
lactate clearance, base excess, and the “CO2 gap” [29] were used as measures of
resuscitative ‘success’.
Conclusions
In a large animal model of complex hemorrhagic shock and pressure-targeted
resuscitation, there was a wide variation in both macrocirculatory flow and microcircu-
latory perfusion. Pressure-based monitoring did not discriminate between animals with
Hutchings et al. Intensive Care Medicine Experimental  (2016) 4:17 Page 11 of 13
poor and preserved perfusion. Animals with above average microcirculatory perfusion
had more timely reversal of the shock state during subsequent resuscitation. If trans-
lated to the clinical setting, microcirculatory perfusion may represent a useful endpoint
of resuscitation and a potential therapeutic target.
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Introduction: The microcirculation is the physiological
site of oxygen and substrate exchange. Its effectiveness
during circulatory shock is vital for the perfusion of
tissues, and has a bearing on subsequent organ
function and prognosis. Microcirculatory dysfunction
following traumatic haemorrhagic shock (THS) has
been understudied compared with other pathologies
such as sepsis. The aim of the MICROSHOCK study is
to investigate changes seen in the microcirculation of
patients following THS, and to assess its response to
resuscitation. A greater understanding of the behaviour
and mechanisms of microcirculatory dysfunction in this
context may direct future avenues of goal-directed
resuscitation for these patients.
Methods and analysis: This multicentre prospective
longitudinal observational study includes patients who
present as an emergency with THS. Microcirculatory
parameters are recorded using sublingual incident dark
field microscopy alongside measurements of global flow
(oesophageal Doppler and transthoracic
echocardiography). Patients are enrolled into the study
as soon as feasible after they arrive in hospital, and then
at subsequent daily time points. Blood samples are
taken for investigation into the mechanisms of
microcirculatory dysfunction. Sequential Organ Failure
Assessment scores will be analysed with
microcirculatory parameters to determine whether they
correlate with greater fidelity than more conventional,
global circulatory parameters.
Ethics and dissemination: Research Ethics
Committee approval has been granted for this study
(Reference: 14/YH/0078). Owing to the nature of THS,
capacity for informed consent will be absent on patient
enrolment. This will be addressed according to the
Mental Health Capacity Act 2005. The physician in
charge of the patient’s care (nominated consultee) may
consent on behalf of the patient. Consent will also be
sought from a personal consultee (close relative or
friend). After capacity is regained, the participant will be
asked for their consent. Results will be submitted for
publication in peer-reviewed journal format and
presented at relevant academic meetings.
Trial registration number: NCT02111109;
Pre-results.
BACKGROUND
Massive haemorrhage and associated shock is
a leading cause of preventable death among
casualties with severe traumatic injury,
accounting for around 40–50% of all
deaths.1 2 Despite signiﬁcant improvements
in treatment and mortality within this patient
group, systemic inﬂammatory response, coa-
gulopathy and subsequent multiple organ
failure remain common.3 These issues can
lead to prolonged periods of morbidity, crit-
ical care dependency and often death.
Therapeutic interventions that attenuate
these responses may lead to signiﬁcant
beneﬁt for patients who have suffered trau-
matic haemorrhagic shock (THS).3
The microcirculation is of particular clin-
ical importance during circulatory shock
Strengths and limitations of this study
▪ This study’s main strength is that it will be the
largest clinical investigation into the microcircu-
latory response to traumatic injury and haemor-
rhagic shock to date.
▪ The MICROSHOCK study will recruit from major
trauma centres in London and Birmingham, the
two largest cities in the UK.
▪ The study is limited by its observational nature.
However, the key research question ‘Does the
microcirculatory behaviour predict outcome
better than global haemodynamic parameters?’
can be addressed using observational data.
▪ A further limitation is the heterogeneous nature
of injury patterns in the UK trauma patient popu-
lation. Such differences will be addressed during
data analysis, and reported during the dissemin-
ation of the results. These differences will be
much greater than those in animal studies.
However, a clinical study allows us to translate
what has been learnt from animal research into
useful and clinically relevant knowledge.
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since it is this network of capillaries and other small
vessels that perform the essential functions of delivering
oxygen and substrates to cells. Traditionally, resuscitative
strategies are guided by measurement of global haemo-
dynamic parameters such as blood pressure and cardiac
output. However, there may be a poor correlation
between such global parameters and the appearance of
the microcirculation.4 5 Microcirculatory parameters
may also predict outcome better than more conven-
tional global circulatory measurements in sepsis.6
Observational data suggest patients who can improve
the state of the microcirculation in response to resusci-
tative ﬂuid therapy have a better outcome than those
who cannot.7 8
Incident dark ﬁeld (IDF) video microscopy is a
method of assessing the microcirculation that has
been developed relatively recently for clinical and
research.9 A light source is applied to the tissue,
which illuminates the deep tissues within the target
ﬁeld. The reﬂected light from the deep tissues is
captured and magniﬁed before being received on a
viewer. The selective wavelength of transmitted light is
completely absorbed by both oxygenated and deoxy-
genated haemoglobin, and blood vessels therefore
appear black. The technique is limited to organs that
have a thin epithelial covering and that are accessible
to a handheld probe, which in clinical practice has
usually been the sublingual microcirculation. The
device is small, portable and the technique
non-invasive. Obtaining images with the device
requires between 2 and 5 min and involves the use of
a small, non-traumatic sublingual probe. The images
produced by IDF microscopy require ofﬂine analysis
and the ascription of objective values before they can
be used. De Backer et al10 have standardised this
approach.
Most clinical studies that examine the microcircula-
tion have focused on sepsis,7 11 12 whereas studies
relating to haemorrhagic shock are mostly limited to
animal experiments, and have usually looked at con-
trolled haemorrhagic shock rather than a complex
traumatic injury model.13–15 One clinical study has
examined the microcirculation after THS once the
patients had been admitted to the intensive care unit
(ICU), but did not gather data during the early
phases of resuscitation.16 Although they share similar-
ities, septic and haemorrhagic shock must be exam-
ined separately in a clinical context, so that their
respective differences can be delineated, and
unanswered questions can be addressed.
Primary objective
The primary objective of the MICROSHOCK study is to
examine the microcirculatory function in patients follow-
ing THS, and to determine whether these parameters
are superior to global haemodynamic parameters in the
prediction of clinical outcomes.
METHODS
Study design
This is a multicentre prospective longitudinal observa-
tional study that involves serial assessments of the sublin-
gual microcirculation alongside measurements of global
ﬂow, volume status and blood pressure, determined
from existing monitoring devices and using focused
transthoracic echocardiography. In conjunction, data
will be gathered relating to the patients physiology and
resuscitation.
Patient screening
All patients with a history of traumatic injury presenting
to the emergency department (ED) at the study site hos-
pitals will be screened by research staff. These sites are
all UK Major Trauma Centres, and include (1) Kings
College Hospital, London, UK; (2) The Royal London
Hospital, London, UK; and (3) Queen Elizabeth
Hospital Birmingham, Birmingham, UK. Patient details
will be recorded in a screening log.
Number of patients
A single pilot study demonstrated feasibility in the exam-
ination of the microcirculation following THS, and
reported data for 18 patients.16 The current study will be
the ﬁrst to examine the microcirculation of patients with
THS as soon as they have arrived in the ED. The
MICROSHOCK study will enrol 60 patients in order to
further investigate the microcirculation following THS,
and form hypotheses that might direct future goal-
directed interventions.
Inclusion criteria
Adult patients with evidence of haemorrhagic shock
exhibiting all of the following features:
1. Mechanism of injury consistent with blood loss;
2. Intubated and ventilated;
3. Serum lactate concentration >2 mmol/L recorded at
any stage prior to admission to the ICU;
4. Have received any blood products (eg, packed red
blood cells (PRBC), fresh frozen plasma (FFP), cryo-
precipitate, platelets) during the initial period of
resuscitation, prior to admission to ICU, or are pre-
dicted to receive blood products during this time-
frame in the opinion of the trauma team leader.
Exclusion criteria
Patients with facial injuries, where access to the sublin-
gual area would be problematic will be excluded.
Patients with injuries deemed unsurvivable in whom the
focus of care is palliation rather than active treatment
are also ineligible for inclusion.
Time points and techniques for data collection
Figure 1 outlines the techniques that will be utilised,
samples taken and data collected at each time point.
There are ﬁve main time points:
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1. As soon as feasible after arrival in hospital (T1), and
up to every 60 min until haemodynamically stable;
2. On admission to ICU (D0);
3. 24 h after D0;
4. 48 h after D0;
5. 72 h after D0.
Where feasible, and appropriate, further readings will
be taken between the ﬁrst and second time points. Data
collection is stopped once the patient has been
extubated.
Demographic and resuscitation data
The following baseline (hospital admission) demo-
graphic and physiological data will be collected from
study participants and recorded in an electronic data-
base on a secure encrypted computer used only for
research purposes. All data in this log will be anon-
ymised and assigned a sequential study number.
▸ Demographic details (age, gender, ethnicity);
▸ Mechanism of injury;
▸ Injury Severity Score (ISS);
▸ Admission systolic blood pressure (SBP), respiratory
rate and Glasgow Comas Scale (GCS; to calculate
Trauma and Injury Severity (TRISS) score);
▸ Administered prestudy blood products and intraven-
ous ﬂuids;
▸ Timings from injury to start of prehospital resuscita-
tion, ED resuscitation and operating theatre-based
resuscitation;
▸ Nature of initial surgical procedures and treatments.
Acquisition of IDF images
The investigator will obtain video clips of the sublingual
microcirculation using an IDF videomicroscope
(Cytocam, Braedius Medical B.V., Huizen, The
Netherlands). In accordance with international consen-
sus criteria for assessing the microcirculation, enough
video will be recorded to enable at least three (and pref-
erably ﬁve) ×10 s video clips to be obtained at each time
point. Because the microcirculation can demonstrate
considerable heterogeneity, particularly in shock states,
images will be acquired from different sites within the
sublingual area. When acquiring images, investigators
should actively seek to minimise pressure artefact by
observing ﬂow in medium and large vessels. The image
should be stabilised with minimal movement artefact.
Light intensity and focus should be optimised.
Individual video sequences will be exported from the
image acquisition software as DV-AVI ﬁles.
Acquisition of transthoracic echo images
Subcostal and apical ﬁve-chamber windows will be
obtained. The inferior vena cava will be visualised in M
mode, and the minimum and maximum diameters
across the respiratory cycle recorded. The left ventricular
outﬂow tract (LVOT) will be visualised and a pulsed
wave Doppler signal acquired. The LVOT velocity time
integer (VTi) and the degree of variation across the
respiratory cycle will both be recorded.
Figure 1 Sampling and techniques. BP, blood pressure; ED, emergency department; GCS, Glasgow Comas Scale; ICU,
intensive care unit; IDF, incident dark field; HR, heart rate; RR, respiratory rate.
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Oesophageal Doppler
An oral oesophageal Doppler probe (Deltex Medical,
Chichester, UK) will be inserted at the same time as
acquisition of the ﬁrst IDF images. The probe will
remain in situ continuously for 72 h or until the patient
is ready for extubation. The following data will be
recorded: corrected ﬂow time, stroke volume, cardiac
output. Data obtained from this monitoring device will
also be available for use to the patients’ attending clini-
cians if they wish.
Thromboelastography (ROTEM)
A 5 ml sample of blood will be withdrawn from existing
vascular access devices and used to perform
point-of-care analysis of coagulation status using the
technique of thromboelastography (ROTEM). The fol-
lowing values will be recorded: EXTEM/FIBTEM CFT,
A5, A10, MCF, LY 30.
Biological sampling
Samples of blood and urine will be withdrawn from exist-
ing vascular access devices and stored for later assessment
of the mechanisms of microcirculatory dysfunction.
Physiological and pharmacological data
The following parameters will also be recorded at every
time point where available:
▸ SBP, diastolic blood pressure and mean arterial blood
pressure;
▸ Central venous pressure;
▸ Heart rate;
▸ Arterial Blood Gas Data (including lactate, base
deﬁcit, arterial oxygen saturation, arterial carbon
dioxide saturation)
▸ Haemoglobin concentration;
▸ Central Venous Blood Gas Data (central venous
oxygen saturation (ScvO2), central venous carbon
dioxide saturation (ScvCO2));
▸ Plasma (free) haemoglobin;
▸ Administration of blood, blood products and bolus
challenges of other intravenous ﬂuids since the previ-
ous time point;
▸ Type of sedative drug infusions currently being
administered;
▸ Type and dose of inotropic and vasopressor drugs
currently being administered.
Primary outcome
The primary outcome is the Sequential Organ Failure
Assessment (SOFA) score at the D3 time point (72 h after
admission to ICU), and will be recorded using information
from the patients’ charts and laboratory results.
Secondary outcomes
Secondary outcomes include SOFA scores and multior-
gan dysfunction score on days 1, 7 and 28 of hospital
admission (if the patient is still an inpatient), mortality
at 28 days, length of stay (LOS) in hospital, LOS in ICU,
number of days of mechanical ventilation,
thromboelastography parameters, arterial and venous
blood gas parameters, and blood product requirements.
Analysis of IDF video sequences
Prior to analysis, the recorded video sequences will be
edited into at least three (and no more than ﬁve) video
clips. All clips will be rated for quality using a ﬁve-point
scale.17 Substandard images will be rejected. All IDF images
will be analysed using a dedicated software tool
(Automated Vascular Analysis V.3.02, Microvision Medical,
The Netherlands). This is a semiautomated process which
produces a number of data points from the video sequence.
Analysis of the video clips will produce the following data:
▸ Microvascular ﬂow index;
▸ Total vessel density;
▸ Perfused vessel density;
▸ Proportion of perfused vessels
▸ Microcirculatory heterogeneity index.
This process is in accordance with recommendations
made by an international consensus conference on
assessing the microcirculation.10 Interobserver variation
will be tested at regular intervals in order to minimise
heterogeneity of data analysis between investigators. At
the time of analysis, the investigators will be blinded
with respect to the clinical time point of the study, the
patients’ details, and the other outcome variables (SOFA
score and haemodynamic data).
The following relationships will be examined:
▸ Between microcirculatory parameters during the post-
resuscitation period and the development of SOFA
scores;
▸ Between microcirculatory parameters and systemic
haemodynamic data (stroke volume, cardiac output,
blood pressure);
▸ Between microcirculatory parameters and plasma
lactate and ScvO2 over the resuscitation period;
▸ Between microcirculatory parameters and coagulation
parameters as assessed by ROTEM.
Capacity and consent
This study complies with the Declaration of Helsinki,
and will be conducted in accordance with the principals
of Good Clinical Research Practice (GCP). In order to
assess the response of the microcirculation to haemor-
rhagic shock and resuscitation, intubated and ventilated
patients will be recruited to the study at an early stage
following their admission to hospital, when capacity for
informed consent will be absent.
Lack of patient capacity will be addressed by referring
to the Mental Health Capacity Act (2005). In this situ-
ation, the physician in charge of the care of the patient
(nominated consultee) will be consulted in order to
consent on behalf of the patient. These physicians will
have received prior brieﬁng on the study protocol, and
will not be a study investigator. If possible consent will
also be sought from a personal consultee (the next of
kin, relative or friend of the patient). When the patient
regains capacity, the study will be explained and the
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participant asked for their consent to use the data col-
lected so far, as well as any further samples required by
the protocol. If the participant declines consent and
wishes to be removed from the study, their data will be
erased and no further samples will be collected.
Patients who die or who do not regain capacity within
28 days of injury will have their data entered into the
study in accordance with the wishes of their personal or
nominated consultee. This process is summarised in
ﬁgure 2.
Confidentiality, data storage and security
All data relating to study participants will be treated in
accordance with the Data Protection Act, 1998. All study
data will be stored on a secure encrypted laptop used
exclusively by the study investigators. Patients will be
assigned an alphanumeric sequential study number that
will be used to identify all clinical data. These numbers
will be speciﬁc to each site. The patients’ demographic
details will be linked to the study number on a separate
screening database held on the secure computer at each
site. Individual IDF image sequences will be assigned a
random ﬁve-digit number. Identiﬁcation of these video
sequences will be achieved by cross-reference with an
electronic database. On completion of the study, all par-
ticipant identifying information and other study data will
be securely archived in accordance with the policy of the
sponsoring institution. All biological samples will be
Figure 2 Process flow chart.
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identiﬁable only by study number, and once analysis is
complete the samples will be disposed off.
Safety
The chief investigator has overall responsibility for the
conduct of the study including responsibility for safety.
Individual investigators will be responsible for reporting
all serious adverse events (SAEs) and adverse events
(AEs) to the chief investigator. There are no reported
AEs associated with the use of IDF imaging in the pub-
lished literature, and the risk of harm occurring to a
study participant as a direct result of undergoing IDF
imaging is close to zero. An example of an attributable
AE would be a sublingual haematoma following IDF
microscopy. SAEs will include death, any event which
poses a threat to life, prolongs hospital stay or produces
signiﬁcant disability. Given the nature of the study popu-
lation, it is anticipated that such features will be rela-
tively common as part to the pathological process of
trauma, but not as a result of participation in the study.
The chief investigator will review all events to decide if
there is any causal link. If this is the case action will be
taken in accordance with the principals of ICH GCP.
Statistical analysis
Normally distributed data will be presented as mean and
SD, and non-normally distributed data will be presented as
median and IQR. For comparison, patients will be dichoto-
mised according to day 3 SOFA score into those with a
score ≥6 versus those with SOFA score <6. The score of 6
has been chosen due to its prognostic relevance18 and pre-
vious utilisation as an end point for haemorrhagic trauma
patients.16 Further analysis will be conducted according to
the change in SOFA scores between days 1 and 3, so that
patients are dichotomised into SOFA score ‘improvers’ and
‘non-improvers’. This approach has also been used as an
end point for haemorrhagic trauma patients.19 Groups will
be compared using a two-tailed t test for normally distribu-
ted data and the Mann-Whitney U test for non-normally
distributed data. A p value of <0.05 will be considered statis-
tically signiﬁcant.
DISCUSSION
Bedside point-of-care technology that enables direct visu-
alisation of the microcirculation offers an opportunity to
gain insight into the real-time behaviour of the site of
oxygen and nutrition exchange during shock. Although
this has been primarily been a research tool in the past,
advances in microcirculatory imaging may pave the way
for a future clinical role.20 In particular because real-
time assessment of images by clinicians may be as reli-
able as detailed ofﬂine computer analysis.21
Further research into bedside microcirculatory
imaging, and the assessment of microcirculatory para-
meters as end points for resuscitation have been recom-
mended by other investigators.22 The current study aims
to address important questions with regard to the
microcirculation during THS. Of particular interest is to
investigate any immediate microcirculatory derangement
on arrival in hospital following traumatic haemorrhagic
injury, and whether there is a relationship between these
changes and clinical outcomes. It is also not fully known
whether there is a persistent microcirculatory derange-
ment following initial resuscitation, and whether there is
a relationship between this and subsequent organ dys-
function. Only one clinical study has reported such a
ﬁnding,16 but this was a relatively small study, with high
usage of vasopressors, which is a relatively uncommon
practice in the UK. Further data are required in order
to fully answer this research question. If there is a true
lack of coherence between macro haemodynamic para-
meters (eg, cardiac output and blood pressure) when
compared with microcirculatory parameters, then this
may strengthen the argument to improve techniques
and technology to enable bedside microcirculatory mon-
itoring. The results of this study will be examined with
these clinical questions in mind.
Trauma patients are heterogeneous, with multiple con-
founding variables that make interpretation of data more
difﬁcult than an animal model may offer. Nevertheless, a
clinical study is both timely and necessary in order to start
the process of translating what has been learnt from
animal research into useful and clinically relevant knowl-
edge. The Microshock study will be the ﬁrst to enrol
patients with THS as soon as they arrive in hospital.
Measuring microcirculatory parameters this soon after
injury offers an opportunity to gain a greater insight into
the early processes and mechanisms of microcirculatory
dysfunction in this context. If clinically relevant details are
discovered, then this may enable future investigators to
determine the priorities and processes that may be put in
place to move the technology towards clinical utilisation.
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Objectives: To assess the relationship between microcirculatory 
perfusion and multiple organ dysfunction syndrome in patients fol-
lowing traumatic hemorrhagic shock.
Design: Multicenter prospective longitudinal observational study.
Setting: Three U.K. major trauma centers.
Patients: Fifty-eight intubated and ventilated patients with trau-
matic hemorrhagic shock.
Interventions: Sublingual incident dark field microscopy was per-
formed within 12 hours of ICU admission (D0) and repeated 24 
and 48 hours later. Cardiac output was assessed using oesopha-
geal Doppler. Multiple organ dysfunction syndrome was defined 
as Serial Organ Failure Assessment score greater than or equal 
to 6 at day 7 post injury.
Measurements and Main Results: Data from 58 patients were ana-
lyzed. Patients had a mean age of 43 ± 19 years, Injury  Severity 
Score of 29 ± 14, and initial lactate of 7.3 ± 6.1 mmol/L and 
received 6 U (interquartile range, 4–11 U) of packed RBCs dur-
ing initial resuscitation. Compared with patients without multiple 
organ dysfunction syndrome at day 7, patients with multiple organ 
dysfunction syndrome had lower D0 perfused vessel density 
(11.2 ± 1.8 and 8.6 ± 1.8 mm/mm2; p < 0.01) and microcirculatory 
flow index (2.8 [2.6–2.9] and 2.6 [2.2–2.8]; p < 0.01) but similar 
cardiac index (2.5 [± 0.6] and 2.1 [± 0.7] L/min//m2; p = 0.11). 
Perfused vessel density demonstrated the best discrimination for 
predicting subsequent multiple organ dysfunction syndrome (area 
under curve 0.87 [0.76–0.99]) compared with highest recorded 
lactate (area under curve 0.69 [0.53–0.84]), cardiac index (area 
under curve 0.66 [0.49–0.83]) and lowest recorded systolic 
blood pressure (area under curve 0.54 [0.39–0.70]).
Conclusions: Microcirculatory hypoperfusion immediately following 
traumatic hemorrhagic shock and resuscitation is associated with 
increased multiple organ dysfunction syndrome. Microcirculatory vari-
ables are better prognostic indicators for the development of multiple 
organ dysfunction syndrome than more traditional indices. Microcir-
culatory perfusion is a potential endpoint of resuscitation following 
traumatic hemorrhagic shock. (Crit Care Med 2018; XX:00–00)
Key Words: critical care; hemorrhage; microcirculation; shock; trauma
Hemorrhage remains the leading cause of preventable mortality following major trauma (1–3). Although some of these deaths result from uncontrolled blood 
loss and overt exsanguination, others occur later as a result of 
multiple organ dysfunction syndrome (MODS)—the prevalence 
of which has been reported as between 7% and 29% (4–7). The 
mechanisms that lead to MODS after traumatic hemorrhage are 
yet to be clearly elucidated, but several observational cohort stud-
ies have shown that the degree of shock, assessed using surrogate 
markers such as lactate concentration or base deficit, is associated 
with the magnitude of subsequent organ dysfunction (4, 6, 8).DOI: 10.1097/CCM.0000000000003275
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A key element of effective tissue perfusion after traumatic 
hemorrhagic shock (THS) and resuscitation is the mainte-
nance of blood flow through the network of small microvessels, 
which represent the final pathway for cellular oxygen and sub-
strate delivery. The state of microcirculatory perfusion has been 
shown to influence outcome in experimental models of THS (9, 
10) and has also been implicated in the development of early 
posttraumatic organ failure in patients in a single-center study 
involving 18 patients (11). The development of hand-held point 
of care video microscopes has allowed real-time in vivo assess-
ment of the microcirculation in clinical practice (12).
The aim of the present study was to examine the association 
between microcirculatory impairment and MODS in a larger 
cohort of patients admitted to three major trauma centers 
in the United Kingdom and to investigate whether there is a 




A multicenter prospective longitudinal observational study 
was undertaken at three U.K. major trauma centers (King’s 
College Hospital London, The Royal London Hospital, and 
Queen Elizabeth Hospital Birmingham). Data were collected 
on the state of the microcirculation in patients with traumatic 
hemorrhage at three time points: D0, following bleeding con-
trol procedures, but less than 12 hours after admission to the 
ICU, D0 + 24 hours (D1), and D0 + 48 hours (D2). Data were 
also collected at these time points relating to the state of the 
systemic circulation. Daily organ failure scores were calculated 
for the first 7 days of hospital admission.
The study received ethical approval from a Research Ethics 
Committee (REC) (Yorkshire and the Humber—Leeds West; 
Ref 14/YH/0078) and was registered at Clinical Trials.gov 
(NCT02111109). The full study protocol was published (13).
Inclusion and Exclusion Criteria
Patients were eligible for inclusion if they had been injured, 
had required blood product transfusion during resuscitation, 
had a lactate concentration of greater than 2 mmol/L at any 
stage prior to enrollment, and were intubated and ventilated. 
Study enrollment took place as early as was feasible following 
arrival in hospital and up to 12 hours after admission to ICU. 
Patients were excluded from the study if they had unsurviv-
able injuries with a palliative focus of care or if they had facial 
injuries that precluded hand-held videomicroscopy. Due to 
the emergency nature of the admission, a system of deferred 
informed consent was approved by the REC.
Microcirculatory Measurements
An assessment was made of microcirculatory perfusion using 
incident dark field (IDF) videomicroscopy (Cytocam; Brae-
dius Medical, Huizen, the Netherlands) (14). Briefly, the video 
microscope is gently placed under the tongue until a view 
of the sublingual microcirculation is acquired. At least four 
video clips of 5 seconds (100 frames) duration are recorded, 
with due attention to quality factors, especially the absence of 
pressure artefact, in accordance with the accepted consensus 
for assessing the microcirculation (15, 16). Clips were deiden-
tified and stored until a later date, at which point en masse 
blinded analysis was undertaken away from the patient. IDF 
videomicroscopy was performed by study investigators after 
comprehensive training by the chief investigator (S.D.H.), who 
was responsible for ensuring consistent, high-quality imag-
ing across study sites. Microcirculatory videos were analyzed 
by a single operator using automated vascular analysis (AVA) 
v.3.02 (Microvision Medical, Amsterdam, The Netherlands) 
and manually tracing all vessels by hand. These video analyses 
give values for total vessel density (TVD), perfused vessel den-
sity (PVD), proportion of perfused vessels (PPV), microcircu-
latory flow index (MFI), and microcirculatory heterogeneity 
index (MHI), according to the current best practice guide-
lines for reporting microcirculatory variables (17). It should 
be noted that the calibration settings used in AVA software are 
of vital importance when calculating the density-related vari-
ables (TVD, PVD), and changes in these settings will produce 
significant variation in density values between studies. The 
calibration settings used in the present study are provided in 
the supplementary material (Supplemental Digital Content 1, 
http://links.lww.com/CCM/D691). An example of a sublingual 
dark field video image is provided in Video 1 (Supplemental 
Digital Content 2, http://links.lww.com/CCM/D692).
Macrocirculatory and Physiologic Measurements
Cardiac output was concurrently assessed using an oesopha-
geal Doppler monitor (Deltex Medical, Chichester, United 
Kingdom). Blood was drawn from arterial and central venous 
catheters (when placed) and used to determine lactate, base 







. Standard physiologic variables were 
recorded using existing monitoring devices. We decided a priori 
to discontinue hemodynamic and microcirculatory measure-
ments following extubation for two reasons. First, oesophageal 
Doppler monitoring is not feasible in awake patients. Second, 
although sublingual videomicroscopy is possible in extubated 
patients, it is our experience and that of others (18) that the 
quality of sublingual videomicroscopy is substantially reduced 
in conscious, noncooperative patients, a typical circumstance 
in the recently extubated critically ill patient.
Outcomes
Organ failure was assessed using Sequential Organ Failure 
Assessment (SOFA) (19, 20) and Denver (21) scores every day 
for the first 7 days following injury. Full details of the SOFA 
and Denver scoring systems are provided in the supplemen-
tal material (Supplemental Digital Content 1, http://links.lww.
com/CCM/D691). The primary outcome was the presence 
or absence of MODS at day 7 following injury; MODS was 
defined as a SOFA score of 6 or higher. Patients who had died 
by day 7 following injury were assigned maximum SOFA and 
Denver scores (24 and 12, respectively) for the day of death 
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and each subsequent day until day 7. Twenty-eight–day mor-
tality and length of stay in ICU were also recorded as secondary 
outcomes.
Statistical Analysis
Statistical analysis was conducted using Prism v 6.0 (Graph-
Pad Software, San Diego, CA). Data were assessed for normal-
ity using the D’Agostino and Pearson omnibus normality test; 
values are reported as reported as mean (SD) or median (inter-
quartile range).
In order to compare patients who developed MODS with 
those who did not, patients were dichotomized into two groups 
based on the development of MODS at day 7. Differences in 
variables at the initial (D0) time point for these patients were 
assessed using unpaired t tests or Mann-Whitney U tests. 
Differences in daily organ failure rates over time between 
patients based on initial (D0) microcirculatory perfusion were 
assessed using repeated measures two-way analysis of variance 
with Sidak’s multiple comparison test.
In order to determine the predictive value of selected vari-
ables, receiver operator characteristic (ROC) curves were 
constructed to predict the incidence of MODS by plotting 
sensitivity versus (1–specificity) for different threshold values 
of PVD, MFI, highest lactate, lowest systolic blood pressure 
(SBP), and cardiac index.
A further analysis was planned in order to determine the 
best fit predictive value for the microcirculatory variable that 
exhibited the largest area under the ROC curve. This was per-
formed using the Youden index (22) for that microcirculatory 
variable, calculated by determining the J value (sensitivity + 
specificity–1) for each threshold measurement. The threshold 
measurement with the largest J value was selected as the best fit 
or cutoff value for determining MODS.
A p value of less than 0.05 was taken to indicate significance.
RESULTS
Patient Characteristics
There were 60 patients enrolled from July 2014 to April 2017. 
Data from two patients were excluded due to insufficient quality 
of microcirculatory video clips, so that all further analysis was 
performed for 58 study patients. Patients were generally young 
(43 ± 19 yr) and male (81%) with severe injuries (Injury Sever-
ity Score 29 ± 14). Patients were enrolled in the study on aver-
age 9 hours (3–13 hr) following injury and 1.5 hours (0–6 hr) 
after admission to ICU. The mechanism of injury in the major-
ity of patients was blunt (75%) with transport-related acci-
dents most common (53%), followed by falls (17%) and crush 
injuries (7%). Those with a penetrating mechanism of injury 
included one with a gun-shot wound, whereas the remainder 
sustained knife injuries. The median number of packed RBCs 
(PRBC) transfused during initial resuscitation (from injury 
until D0) was 6 U (4–11 U) , and 29% of patients received a 
massive transfusion (defined as > 10 U PRBC in the first 24 hr). 
Enrolled patients exhibited signs of shock and hemodynamic 
compromise; the mean highest recorded lactate concentration 
prior to ICU admission was 7.3 ± 6.1 mmol/L, and mean low-
est recorded SBP was 69 ± 27 mm Hg. Eight patients (13%) suf-
fered a traumatic brain injury (TBI) in addition to their other 
injuries. The majority of patients had surgical control of hem-
orrhage (81%), 10% had combined surgical and interventional 
radiologic (IR) control of bleeding, 2% IR alone, and 7% were 
managed conservatively. The vast majority of resuscitative fluid 
(blood products and crystalloid/colloid) was given prior to 
study enrollment, and the D0 time point therefore represents 
a period of relative hemodynamic stability following resusci-
tation. Full details of fluid and vasopressor administration are 
provided in Table S.1 (Supplemental Digital Content 1, http://
links.lww.com/CCM/D691).
Outcomes
Patient characteristics according to development of MODS at 
day 7 are shown in Table 1.
Microcirculatory variables at all time points according 
to the presence of MODS at day 7 are shown in Figure 1. 
Although all enrolled patients had complete data recorded at 
study inclusion (D0), there were a proportion of patients in 
whom data were not obtainable at the D1 and D2 time points; 
this was predominantly due to early patient extubation and 
mostly affected the group without MODS at day 7. Full details 
of these exclusions are contained in Table S.2 (Supplemental 
Digital Content 1, http://links.lww.com/CCM/D691).
There are significant differences between TVD, PVD, MFI, 
and MHI, at the D0 time point, for patients according to sub-
sequent MODS. Conversely, there were no significant differ-
ences in systemic hemodynamic variables (cardiac index, mean 
arterial pressure) between those who developed MODS and 
those who did not. Similarly, there were no differences in nor-
adrenaline dose at D0 between those with and without MODS 
(median dose 0 µg/kg/min [0.25–0.53 µg/kg/min] and 0 µg/kg/
min [0.05–0.38 µg/kg/min], respectively; p = 0.10).
Comparison of Variables Used for the Prediction of 
MODS
ROCs curves were constructed for several variables to pre-
dict the development of MODS (Fig. 2). The microcircula-
tory variables of PVD and MFI had area under curve (AUC) 
values of 0.87 (0.76–0.99) and 0.83 (0.71–0.95), respectively. 
These values provided a more accurate prediction of MODS 
at day 7 than cardiac index (AUC, 0.66 [0.49–0.83]) or high-
est recorded lactate prior to ICU admission (AUC, 0.69 
[0.53–0.84]). The lowest recorded SBP appeared to be the least 
predictive variable for the development of MODS (AUC, 0.54 
[0.39–0.70).
Factors Associated With Postresuscitation 
Microcirculatory Impairment
Based on the ROC curve analysis, PVD was selected as the micro-
circulatory variable with the best discrimination at predicting 
MODS. The threshold value for PVD which represented the best 
fit for MODS prediction was 10.33 mm/mm2. Figure 3 shows 
mean daily organ failure scores for patients with D0 PVD scores 
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of greater or less than 10.33 mm/mm2. At each day from day 4 to 
day 7 after injury, patients with initial (D0) PVD values of less 
than 10.33 mm/mm2 had significantly higher organ failure scores 
than those with PVD values of greater than 10.33 mm/mm2. For 
those patients with a SOFA score of greater than 6 at day 7, the 
greatest contributor to the score was the CNS component (28 
total points), followed by the cardiovascular and respiratory 
components (19 and 17 points, respectively). The renal, liver, and 
hematology components were relatively small contributors to an 
elevated SOFA score (scores of 8, 4, and 4, respectively).
Patient characteristics were then compared between patients 
according to their PVD value recorded at study inclusion (D0), 
again dichotomized to above or below a PVD of 10.33 mm/mm2 
(Table 2). Other reported variables are also recorded at the D0 
time point unless otherwise stated. Patients in the lower PVD 
group received more crystalloid fluid during resuscitation, but 
there were no observed differences in the amount of administered 
blood products between the groups. The noradrenaline dose in 
both groups was extremely low in the immediate postresuscita-
tion period. Patients with lower PVD had a significantly higher 
TABLE 1. Characteristics of Study Patients With or Without Multiple Organ Dysfunction 
Syndrome at Day 7 After Injury
Patient Characteristics SOFA ≥ 6 (n = 23) SOFA < 6 (n = 35) p
Age, median (IQR) 49 (28–74) 36 (27–46) 0.06
Injury Severity Score, mean ± SD 35 (± 12) 25 (± 14) 0.01a
Resuscitation fluids prior to bleeding control procedures, but 
< 12 hours after admission to the ICU
   
 Packed RBC, units, median (IQR) 6 (4–13) 6 (3–8) 0.20
 Fresh frozen plasma, units, median (IQR) 5 (4–10) 4 (2–8) 0.39
 Crystalloids, mL, median (IQR) 2,900 (225–6,125) 2,000 (0–3,500) 0.19
Noradrenaline dose, µg/kg/min, median (IQR) 0 (0–0.25) 0 (0–0.05) 0.10
Microcirculatory variables    
 Total vessel density, mm/mm2, mean ± SD 10.6 (± 1.6) 11.8 (± 1.6) < 0.01a
 Perfused vessel density, mm/mm2, mean ± SD 8.6 (± 1.8) 11.2 (± 1.8) < 0.01a
 Microcirculatory flow index, AU, median (IQR) 2.6 (2.2–2.8) 2.8 (2.6–2.9) < 0.01b
 Proportion of perfused vessels, %, median (IQR) 88 (76–96) 96 (92–99) < 0.01b
 Microcirculatory heterogeneity index, AU, median (IQR) 0.9 (0.5–1.2) 0.35 (0–0.39) < 0.01b
Systemic hemodynamic variables, mean ± SD    
 Cardiac index, L/min/m2, mean ± SD 2.1 (± 0.7) 2.5 (± 0.6) 0.11
 Mean arterial pressure, mm Hg, mean ± SD 76 (± 18) 81 (± 15) 0.26
 Lowest systolic blood pressure pre-ICU, mm Hg, mean ± SD 66 (± 24) 71 (± 28) 0.53
 Hemoglobin (g/dL), mean ± SD 10.8 (± 1.9) 11.9 (± 1.9) 0.053
Tissue perfusion variables    
 Lactate, mmol/L, median (IQR) 4.1 (2.1–6.9) 2.2 (1.4–3.8) < 0.01b
 Base deficit, mmol/L, median (IQR) –5.6 (–8.9 to –2.1) –2.6 (–5.6 to –0.2) 0.05
 Central venous O2 saturation, %, mean ± SD 71.6 (± 5.7) 68.1 (± 7.8) 0.20
 Central venous CO2 tension–PaCO2, kPa, mean ± SD 1.27 (± 0.7) 1.1 (± 0.5) 0.51
 Highest lactate pre-ICU, mmol/L, median (IQR) 8.5 (4.5–13.6) 4 (2.8–5.1) < 0.01b
Clinical outcomes    
 ICU length of stay, d, mean ± SD 28 (± 14) 12 (± 11) < 0.01a
 28-d mortality, %, n (%) 6 (25) 0 (0) < 0.01c
IQR = interquartile range, SOFA = Sequential Organ Failure Assessment.
a Significant according to t test. 
b Significant according to Mann-Whitney U test. 
c Significant according to χ2. 
All variables are those recorded at following bleeding control procedures, but < 12 hours after admission to the ICU, unless otherwise stated.
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lactate concentration following resuscitation, but there were no 







The main finding of the present study is that early microcircu-
latory hypoperfusion in the period immediately following THS 
and resuscitation is associated with an increased risk of MODS 
a week after injury. Microcirculatory perfusion indices appear 
to be better predictive indicators for the development of MODS 
than other more commonly used markers of posttraumatic 
shock such as lowest SBP or highest plasma lactate concentration.
The results of the current study suggest that microcirculatory 
impairment is an early phenomenon following THS. However, 
our results suggest that the impact of early hypoperfusion per-
sists for up to a week after the initial insult. One possible expla-
nation for these findings may relate to cellular and genomic 
changes that are known to occur very early after injury (23, 
24). It is conceivable that the magnitude of such change may be 
influenced by the degree of early tissue and cellular hypoper-
fusion. Furthermore, given that the measurements in our study 
were made after reperfusion, ischemia-reperfusion injury may 
also have had an impact on the state of the microcirculation 
(25). Whatever the mechanism, our findings suggest the poten-
tial importance of the rapid restoration of tissue perfusion once 
bleeding has been brought under control. Treatment targeted at 
microcirculatory flow is not yet in main stream clinical practice 
but may be moving closer with the development of novel point 
of care measures of microcirculatory perfusion (26, 27).
The findings of the present study are broadly in keep-
ing with a smaller single-center study conducted by Tachon 
et al (11). A comparison of data reported in the current study 
cohort and that of Tachon et al (11) is provided in Table S.3  
(Supplemental Digital Content 1, http://links.lww.com/
CCM/D691). There are many similarities between the two 
cohorts, although the cohort by Tachon et al (11) appeared 
to have a greater burden of injury, received more blood prod-
ucts and other fluids, and had higher lactate concentrations 
Figure 1. Microcirculatory and macrocirculatory variables at all study time points according to multiple organ dysfunction syndrome (MODS) at day 7. 
Patients are dichotomized into those who did or did not develop MODS by day 7 after injury. *p < 0.05 between groups (t test/Mann-Whitney U). NB 
comparative analysis only performed at following bleeding control procedures, but < 12 hours after admission to the ICU (D0) time point due to patient 
drop out at D0 + 24 hours (D1) and D0 + 48 hours (D2). AU = arbitrary units, CI = cardiac index, MAP = mean arterial pressure, MFI = microcirculatory 
flow index, MHI = microcirculatory heterogeneity index, PVD = perfused vessel density, TVD = total vessel density. 
Figure 2. Receiver operator characteristic curves constructed to predict 
the development of multiple organ dysfunction syndrome at day 7 post 
injury. Values are area under curve for variable. The value for lactate 
represents the highest recorded pre-ICU measurement and that for blood 
pressure the lowest recorded pre-ICU measurement. D0 = following 
bleeding control procedures, but < 12 hours after admission to the ICU, 
MFI = microcirculatory flow index, MHI = microcirculation heterogeneity 
index, PVD = perfused vessel density, SBP = systolic blood pressure. 
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following resuscitation. Patients in the cohort by Tachon 
et al (11) were explicitly stated to be hemodynamically stable, 
although it is not clear how this was defined. Patients in the 
current study received the vast majority of resuscitative fluids 
prior to study enrollment and required minimal further vol-
ume administration after this time point (data presented in 
Table S.1, Supplemental Digital Content 1, http://links.lww.
com/CCM/D691). It is therefore reasonable to presume that 
initial measurements in both study cohorts were made at simi-
lar time points after hemorrhage control and resuscitation.
Although both the current study and that reported by 
Tachon et al (11) demonstrate a relationship between micro-
circulatory impairment and organ failure that is independent 
of changes in systemic hemo-
dynamic variables, there are 
important differences in 
the reported microcircula-
tory indices for both density 
(functional capillary density/
PVD) and flow (MFI/PPV). 
Although direct comparison 
of density variables is difficult, 
given the difference in video 
microscopes and without 
knowledge of the calibration 
settings used in the respective 
AVA software packages, flow 
variables (MFI/PPV) should 
be directly comparable and 
appear markedly worse in the 
cohort by Tachon et al (11). 
One possible explanation may be the striking difference in the 
use of vasopressors; patients in the cohort by Tachon et al (11) 
receiving a substantial higher amount of norepinephrine than 
patients in the current study. Whether vasopressor use results 
in impaired microcirculatory flow is controversial and unset-
tled (28–31), and further experimental and prospective clinical 
studies are required.
Persistently high organ dysfunction scores in this cohort 
of patients predominantly resulted from elevated CNS, car-
diovascular and respiratory components with values for the 
renal, liver, and hematology components making little con-
tribution for most patients. This pattern perhaps suggests a 
general ongoing critical care dependency, with failure to wean 
Figure 3. Daily Sequential Organ Failure Assessment (SOFA) and Denver scores for those patients with 
following bleeding control procedures, but < 12 hours after admission to the ICU (D0) perfused vessel density 
(PVD) values of greater or less than 10.33 mm/mm2. Values represent the mean scores of all patients in the 
group at that time point. Patients who died were assigned a maximal score for the day of death and subsequent 
days. *p < 0.05 between groups at time point (two-way analysis of variance). D1 = D0 + 24 hr, D2 = D0 + 48 
hr, D3 = D0 + 72 hr, D4 = D0 + 96 hr, D5 = D0 + 120 hr, D6 = D0 + 144 hr, D7 = D0 + 168 hr.
TABLE 2. Characteristics of Patients With Values of Perfused Vessel Density Above and 
Below a Threshold Value of 10.33 mm/mm2 at the D0 Time Point
Patient Characteristics PVD < 10.33 PVD > 10.33 p
Age, mean ± SD 44 (± 20) 42 (± 19) 0.74
Injury Severity Score, mean ± SD 33 (± 13) 26 (± 14) 0.09
Resuscitation fluids prior to D0, median (IQR)    
 Packed RBC, units 6 (4–11) 6 (4–9) 0.91
 Fresh frozen plasma, units 4.5 (1.7–9.0) 4.5 (2.7–8.2) 0.99
 Crystalloids, mL 3,350 (500–5,000) 2,000 (0–3,500) 0.05
Noradrenaline (µg/kg/min) 0.02 (0.0–0.3) 0 (0–0.07) 0.07
Cardiac index (L/min/m2), mean ± SD 2.2 (± 0.7) 2.6 (± 0.6) 0.09
Tissue perfusion variables    
 Lactate, mmol/L, median (IQR) 3.1 (2.3–5.3) 1.9 (1.5–3.7) 0.02a
 Base deficit, mmol/L, median (IQR) –4.1 (–6.3 to –2.1) –2.6 (–6.7 to –0.1) 0.20
 Central venous O2 saturation, %, mean ± SD 71 (± 9) 69 (± 4) 0.50
 Central venous CO2 tension–PaCO2, median (IQR) 1.36 (0.8–2.0) 1 (0.7–1.3) 0.19
IQR = interquartile range, PVD = perfused vessel density.
a Significant according to Mann-Whitney U test.
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quickly from mechanical ventilation and inotropic support, 
rather than overt fulminant multiple organ failure. A potential 
criticism of the use of the SOFA score in trauma patients is the 
inclusion of a CNS component and the potential for the score 
to be confounded by the presence of TBI. However, there was a 
relatively low prevalence of TBI in this cohort, and no patient 
remained ventilated at day 7 as a result of persistent neurologic 
disability. The addition of the Denver score, which removes the 
CNS component, was used in the present study to overcome 
this potential confounder. Changes in Denver score over time 
are in keeping with the SOFA score, suggesting that these find-
ings are more than an epiphenomenon caused by excess seda-
tion or neurologic obtundation.
In the present study, patients with a lower PVD at D0 
received significantly more crystalloid fluid during resuscita-
tion than those with a PVD above this value. However, there 
were no observed differences in the amount of blood prod-
ucts administered. There are several potential explanations for 
these findings. The results of this study suggest that patients 
with greater degrees of microcirculatory impairment exhibit 
higher lactate concentration and may, as a result, receive more 
resuscitation fluids. Such an explanation presumes that clini-
cians target resuscitation fluid boluses to perfusion-based indi-
ces; however, a recent multinational study has suggested that 
this is not often the case (32). An alternative explanation is that 
poor microcirculatory flow may lead to more injury at the level 
of the endothelium, potentially increasing endovascular leak, 
rendering the patient hypovolemic, with a resultant increase in 
the volume of resuscitation fluid required. Such an explanation 
is supported by recently published evidence from the present 
study cohort (33) demonstrating a link between microcircula-
tory flow and endotheliopathy.
Our study has limitations. Most significant is the partial 
loss of patients from the study over time. These losses were 
not random but mostly due to patient recovery and extubation 
which made further measurements problematic. Although we 
decided a priori to discontinue measurements under these cir-
cumstances, resultant bias precluded comparative analysis at 
the D1 and D2 time points. This should not detract from the 
fact that the development of organ failure at day 7 post injury 
is solely based on analysis of data from the D0 time point for 
which a full dataset was available.
A further limitation is the short length (5 s) of individual 
video sequences used. Although in keeping with the recent 
consensus guidelines suggesting between 5 and 20 s for each 
sequence (17), opting for the shorter end of this range may 
not have allowed for the full assessment of intermittent flow 
in small vessels.
CONCLUSIONS
In conclusion, microcirculatory impairment following THS is 
associated with an increased incidence of organ dysfunction 
at 1 week following injury. Evidence from this study points 
to the initial time point after resuscitation being the point of 
maximal divergence in microcirculatory variables, and future 
studies should focus on early optimization of tissue perfusion 
in an attempt to ameliorate late organ dysfunction following 
traumatic hemorrhagic shock. Treatment strategies that target 
microcirculatory perfusion may be useful in perfusion-based 
resuscitation but are yet to be realized.
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